Mechanisms underlying the vasorelaxant effect induced by proanthocyanidin-rich fraction from Croton celtidifolius in rat small resistance arteries

Journal of Pharmacological Sciences

Volumn 106, Issue 2, 2008, Pages 234-241

  DalBó, Silvia ^a   Moreira, Eduardo Gasnhar ^a   Brandão, Fernanda Costa ^a   Horst, Heros ^b   Pizzolatti, Moacir Geraldo ^b   Micke, Gustavo Amadeu ^b   Ribeiro do Valle, Rosa Maria ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^b Departamento de Geociência   (Brazil)

Author keywords

Croton celtidifolius; Nitric oxide (NO); Proanthocyanidin; Vasorelaxation

Indexed keywords

1H [1,2,3]OXADIAZOLO[4,3 ALPHA]QUINOXALIN; 4 AMINOPYRIDINE; APAMIN; ATROPINE; BARIUM CHLORIDE; CHARYBDOTOXIN; CYCLIC GMP; GLIBENCLAMIDE; GUANYLATE CYCLASE INHIBITOR; ICATIBANT; INDOMETACIN; MEPYRAMINE; N(G) NITROARGININE; NITRIC OXIDE SYNTHASE INHIBITOR; OUABAIN; PHENYLEPHRINE; POTASSIUM; POTASSIUM CHANNEL BLOCKING AGENT; POTASSIUM CHLORIDE; PROANTHOCYANIDIN; UNCLASSIFIED DRUG; YOHIMBINE;

ANALYTIC METHOD; ANIMAL TISSUE; ARTICLE; BARK; COMPARATIVE STUDY; CONTROLLED STUDY; CROTON CELTIDIFOLIUS; HYPERPOLARIZATION; MALE; MEDICINAL PLANT; MESENTERIC ARTERY; NONHUMAN; RAT; RESISTANCE BLOOD VESSEL; VASODILATATION;

EID: 40549116330     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.FP0071119     Document Type: Article

References (34)

1. Santos SC, Mello JCP. Taninos. In: Simões CMO, Schenkel EP, Gosmann G, Mello JCP, Mentz LA, Petrovick PR, editors. Farmacognosia - Da planta ao medicamento. Porto Algre /Florianópolis: Ed. Da UFSC; 1999. p. 517-544.
2. Rasmussen SE, Frederiksen H, Krogholm KS, Poulsen L. Dietary proanthocyanidins: Occurrence, dietary intake, bioavailability, and protection against cardiovascular disease. Mol Nutr Food Res. 2005;49:159-174.
3. De Bruyne T, Pieters L, Deelstra H, Vlietinck A. Condensed vegetable tannins: biodiversity in structure and biological activities. Biochem Syst Ecol. 1999;27:445-459.
4. Chan P, Cheng JT, Tsai JC, Lien GS, Chen FC, Kao PF, et al. Effects of catechin on the activity and gene expression of superoxide dismutase in cultured rat brain astrocytes. Neurosci Lett. 2002;328:281-284.
5. Porto PAL, Laranjinha JAN, Freitas VAP. Antioxidant protection of low density lipoprotein by proanthocyanidins: structure /activity relationships. Biochem Pharmacol. 2003;66:947-954.
6. Koga T, Moro K, Nakamori K, Yamakoshi J, Hosoyama H, Kataoka S, et al. Increase of antioxidant potential of rat plasma by oral administration of proanthocyanidins-rich extract from grape seeds. J Agric Food Chem. 1999;47:1892-1897.
7. Sato M, Maulik G, Ray PS, Bagchi D, Das DK. Cardioprotective effects of grape seed proanthocyanidins against ischemic reperfusion injury. J Mol Cell Cardiol. 1999;3:1289-1297.
8. Dell'Agli M, Buscialà A, Bosisio E. Vascular effects of wine polyphenols. Cardiovasc Res. 2004;63:593-602.
9. Smith LB, Downs RJ, Klein RM. Euphorbiaceae. In: Flora ilustrada catarinense. Itajaí: Herbário Barbosa Rodrigues; 1988. p. 72-75.
10. Nardi GM, Felippi R, DalBó S, Siqueira-Júnior JM, Arruda DC, Delle Monache F, et al. Anti-inflammatory and antioxidant effects of Croton celtidifolius bark. Phytomedicine. 2003;10: 176-184.
11. Nardi GM, Siqueira JM, Delle Monache F, Pizzolatti MG, Ckless K, Ribeiro-do-Valle RM. Antioxidant and anti-inflammatory effects of products from Croton celtidifolius Bailon on carrageenan-induced pleurisy in rats. Phytomedicine. 2007;14: 115-122.
12. Nardi GM, DalBó S, Monache FD, Pizzolatti MG, Ribeiro-do-Valle RM. Antinociceptive effect of Croton celtidifolius Baill (Euphorbiaceae). J Ethnopharmacol. 2006;107:73-78.
13. DalBó S, Jurgensen S, Horst H, Ruzza AA, Soethe DN, Santos AR, et al. Antinociceptive effect of proanthocyanidins from Croton celtidifolius bark. J Pharm Pharmacol. 2005;57:765-771.
14. DalBó S, Jurgensen S, Horst H, Soethe DN, Santos AR, Pizzolatti MG, et al. Analysis of the antinociceptive effect of the proanthocyanidin-rich fraction obtained from Croton celtidifolius barks: evidence for a role of the dopaminergic system. Pharmacol Biochem Behav. 2006;85:317-323.
15. Herrero-Martinez MJ, Rafols C, Roses M, Bosch E, Lozano C, Torress JL. Micellar electrokinetic chromatography estimation of size and composition of procyanidins after thiolysis wit cysteine. Electrophoresis. 2003;24:1404-1410.
16. McGregor DD. The effect of sympathetic nerve stimulation on vasoconstrictor responses in perfused mesenteric blood vessels of the rat. J Physiol. 1965;177:21-30.
17. Côrtes SF, Rezende BA, Corriu C, Medeiros IA, Teixeira MM, Lopes MJ, et al. Pharmacological evidence for the activation of potassium channels as the mechanism involved in the hypotensive and relaxant effect of dioclein in rat small resistance arteries. Br J Pharmacol. 2001;133:849-858.
18. Runnnie I, Salleh MN, Mohamed S, Head RJ, Abeywardena MY. Vasorelaxation induced by common edible tropical plant extracts in the isolated rat aorta and mesenteric vascular bed. J Ethnopharmacol. 2004;92:311-316.
19. Chauhan S, Rahman A, Nilsson H, Clapp L, MacAllister R, Ahluwalia A. NO contributes to EDHF-like responses in rat small arteries: a role for NO stores. Cardiovasc Res. 2003;57:207-216.
20. Smith WL. Prostaglandin biosynthesis and its compartmentation in vascular smooth muscle and endothelial cells. Annu Rev Physiol. 1986;48:251-262.
21. 2+ entry blockade. Clin Exp Pharmacol Physiol. 2006;33:448-455.
22. Mambouli JV, Vanhoutte PM. Endothelium derived hyperpolarizing factors: updating the unknown. Trends Pharmacol Sci. 1997;18:252-256.
23. Gardiner SM, Compton AM, Bennett T, Palmer RM, Moncada S. Control of regional blood flow by endothelium-derived nitric oxide. Hypertension. 1990;15:486-492.
24. Fleming I, Busse R. NO: the primary EDRF. J Mol Cell Cardiol. 1999;31:5-14.
25. Vanhoutte PM. Endothelial dysfunction and vascular desease. In: Panza JA, Cannon RO. 3rd eds. Endothelium, nitric oxide, and atherosclerosis. Armonk, NY: Futura Publishing Co. Inc.; 1999. p. 79-95.
26. Moncada S, Higgs EA. The discovery of nitric oxide and its role in vascular biology. Br J Pharmacol. 2006;147:193-201.
27. Garland CJ, Plane F, Kemp BK, Cocks TM. Endotheliumdependent hyperpolarization: a role in the control of vascular tone. Trends Pharmacol Sci. 1995;16:23-30.
28. Adegbo AS, Triggle CR. Varying extracellular [K+]: a functional approach to separating EDHF- and EDNO-related mechanism in perfused rat mesenteric arterial bed. J Cardiovasc Pharmacol. 1993;21:423-429.
29. Pimentel AML, Costa CA, Carvalho LCRM, Brandão RM, Rangel BM, Tano T, et al. The Role of NO-cGMP pathway and potassium channels on the relaxation induced by clonidine in the rat mesenteric arterial bed. Vascul Pharmacol. 2007;46:353-359.
30. + is an endothelium-derived hyperpolarizing factor in rat arteries. Nature. 1998;19:269-272.
31. Busse R, Edwards G, Feletou M, Fleming I, Vanhoutte PM, Weston AH. EDHF: bringing the concepts together. Trends Pharmacol Sci. 2002;23:374-380.
32. Bhat KPL, Kosmeder II JW, Pezzuto JM. Biological effects of resveratrol. Antioxid Redox Signal. 2001;3:1041-1064.
33. Schuldt EZ, Bet AC, Hort MA, Ianssen C, Maraschin M, Ckless K, et al. An ethyl acetate fraction obtained from a Southern Brazilian red wine relaxes rat mesenteric arterial bed through hyperpolarization and NO-cGMP pathway. Vascul Pharmacol. 2005;43:62-68.
34. Feletou M, Vanhoutte PM. The alternative: EDHF. J Mol Cell Cardiol. 1999;31:15-22.